In both the established cannabis industry and the emerging drug space, federal law has fallen behind in public sentiment. Marijuana, LSD, Mescaline (contained in Peyote), MDMA, Psilocybin (from “magic mushrooms”) are all listed in Schedule I of the Controlled Substances Act (CSA) and are all major topics of interest recently, according to Bloomberg. In addition, states have taken the legalization of these substances into their own hands, legalizing medical cannabis, adult use of cannabis and Legalization or decriminalization of certain narcotics or stimulants. However, the fact that most anthogens and cannabinoids are suspended in Schedule I CSA means that the United States is behind in the search for these mind-altering substances. The cannabis legalization movement has been in the works for decades, and it looks like the federal ban on cannabis will soon be ending. The current push to legalize narcotics is still in its infancy. This post examines what legalizing cannabis can tell us about cannabis.
US cannabis legalization timeline
Despite some similarities, legalizing the drug plays differently from legalizing cannabis, at least in terms of timing. The modern movement to legalize cannabis can trace its first major success in California in 1996, when it became the first state in the country to legalize medical cannabis. Several states have followed suit, including Oregon in 1998. Finally, in 2012, voters in Washington and Colorado decided to legalize adult use of recreational cannabis. Slowly, over time, public opinion regarding cannabis has changed significantly. Now the majority of Americans support National marijuana legalization. With the development of the cannabis industry, the focus has shifted from legalizing medical marijuana to legalizing marijuana for both medical and recreational cannabis.
Instead, public support came quickly for the psychedelic movement. Oregon was the first state to set up a regulator Entheogen in 2020. While it took years for public support to favor cannabis, just months after Oregon legalized psilocybin (and years before the program was actually operational) (a) Report from the hill He points out that more than a third of voters in America actually believe that psychedelics, such as “magic mushrooms,” have medicinal value. Support growth has taken longer to legalize cannabis. Bipartisan support for drug treatment is also rapidly developing, with Former Texas Governor Rick Perry (right) Support legislation that allows clinical research on psilocybin to help war veterans with PTSD.
The drug in the pharmaceutical space
Big money floods the cannabis space much faster than the cannabis market, too. according to Watch dope stock By early 2021, nearly $540 million had been pumped into psychedelic drug companies. as Another article on Psychedelic Stock Watch He points out, “Unlike cannabis, most cannabinoids are better suited to the drug patent system. Translation: Much stronger profit potential for drug companies than cannabis.” While there is certainly “big money” in cannabis, especially investments in multinational operators (MSOs), money has moved more quickly to companies focused on the narcotic.
At this time, it seems unlikely that legalization of the drug will eventually allow non-medical or recreational use of the drug. This drug is distinguished from cannabis in the sense that many countries legalize cannabis for recreational and non-medical use. Simply put, the drug is stronger than cannabis and may not be safe for recreational use. As cannabinoids are better for patent purposes, there is also more incentive to develop cannabinoids.
The drug industry’s priorities: spirituality or commerce?
However, there are other avenues that policy makers should explore in legalizing the drug. For thousands of years, humans have used psychedelics for spiritual or religious purposes. Many entheogens are considered secrets. In the United States, most of the discussion about cannabis has focused on the difference between recreational and medicinal use or the difference between marijuana and hemp. On the other hand, in JamaicaThe legalization of cannabis not only affected medical and recreational cannabis, but also led to the legalization of the use of cannabis in the sacred sacrament, or ganja, in the Rastafarian tradition.
I hope that as states and the federal government begin to legalize and regulate narcotic drugs, there is a place in the industry for both spiritual and traditional use, as is the case with the Ganga in Jamaica. Although legalization of the drug has been quickly pushed back by commercial interests, this does not prevent the drug from being used for non-commercial purposes.
Recreational cannabis vs. recreational drug
The fact that the cannabis legalization movement is similar in many ways to the cannabis movement does not mean that it will or should follow the same path towards legalization. In many ways, the statewide legalization of cannabis has laid the foundation for a rapidly developing psychedelic movement but that doesn’t mean we should expect to see a boost for the recreational drug down the road. Advocates of cannabis legalization should learn from the cannabis movement but should not attempt to re-establish the exact path toward legalization because what makes sense for cannabis may not make sense for the drug.
Source: https://greenlightlawgroup.com/blog/what-can-cannabis-legalization-tell-us-about-psychedelics
